BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gurgey A, Haznedaroglu IC, Egesel T, Buyukasik Y, Ozcebe OI, Sayinalp N, Dundar SV, Bayraktar Y. Two common genetic thrombotic risk factors: factor V Leiden and prothrombin G20210A in adult Turkish patients with thrombosis. Am J Hematol. 2001;67:107-111. [PMID: 11343382 DOI: 10.1002/ajh.1087] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Harmanci O, Buyukasik Y, Kirazli S, Balkanci F, Bayraktar Y. Does endothelium agree with the concept of idiopathic hepatic vessel thrombosis? World J Gastroenterol 2006;12:1273-7. [PMID: 16534884 DOI: 10.3748/wjg.v12.i8.1273] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
2 Aksoy MC, Aksoy DY, Haznedaroglu IC, Sayinalp N, Kirazli S, Alpaslan M. Enhanced tissue factor pathway inhibitor response as a defense mechanism against ongoing local microvascular events of Legg-Calve-Perthes disease. Pediatr Hematol Oncol 2005;22:391-9. [PMID: 16020129 DOI: 10.1080/08880010590964273] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
3 Dölek B, Eraslan S, Eroğlu S, Kesim BE, Ulutin T, Yalçıner A, Laleli YR, Gözükirmızı N. Molecular Analysis of Factor V Leiden, Factor V Hong Kong, Factor II G20210A, Methylenetetrahydrofolate Reductase C677T, and A1298C Mutations Related to Turkish Thrombosis Patients. Clin Appl Thromb Hemost 2007;13:435-8. [DOI: 10.1177/1076029607303341] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
4 Gurgey A, Balta G, Boyvat A. Factor V Leiden mutation and PAI-1 gene 4G/5G genotype in thrombotic patients with Behcet's disease: . Blood Coagulation & Fibrinolysis 2003;14:121-4. [DOI: 10.1097/00001721-200302000-00001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
5 Jadaon MM. Epidemiology of activated protein C resistance and factor v leiden mutation in the mediterranean region. Mediterr J Hematol Infect Dis 2011;3:e2011037. [PMID: 22224194 DOI: 10.4084/MJHID.2011.037] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
6 Yurekli BP, Aksoy DY, Aybar M, Egesel T, Gurgey A, Hascelik G, Kirazli S, Haznedaroglu IC, Arslan S. The search for a common thrombophilic state during the active state of inflammatory bowel disease. J Clin Gastroenterol. 2006;40:809-813. [PMID: 17016137 DOI: 10.1097/01.mcg.0000225603.33481.56] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
7 Eroglu A, Sertkaya D, Akar N. The Role of Factor V Leiden in Adult Patients With Venous Thromboembolism: A Meta-Analysis of Published Studies from Turkey. Clin Appl Thromb Hemost 2012;18:40-4. [DOI: 10.1177/1076029611412369] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
8 Fadel FI, Elshamaa MF, Abdel-Rahman SM, Thabet EH, Kamel S, Kandil D, Ibrahim MH, El-Ahmady M. Coagulation, thrombophilia and patency of arteriovenous fistula in children undergoing haemodialysis compared with healthy volunteers: a prospective analysis. Blood Coagul Fibrinolysis 2016;27:190-8. [PMID: 26829282 DOI: 10.1097/MBC.0000000000000417] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
9 Arslan S, Manduz Ş, Epöztürk K, Karahan O, Akkurt İ. Association of deep venous thrombosis with prothrombotic gene polymorphism identified in lung cancer cases. Mol Biol Rep 2011;38:2395-400. [DOI: 10.1007/s11033-010-0373-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
10 Hwang S, Kim do Y, Kim M, Chon YE, Lee HJ, Park YN, Park JY, Ahn SH, Han KH, Chon CY. [Deficiencies in proteins C and S in a patient with idiopathic portal hypertension accompanied by portal vein thrombosis]. Korean J Hepatol. 2010;16:176-181. [PMID: 20606502 DOI: 10.3350/kjhep.2010.16.2.176] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
11 Bayraktar Y, Harmanci O, Büyükasik Y, Shorbagi AI, Sungur AH, Boylu CA, Gürgey A, Balkanci F. JAK2V617F mutation in patients with portal vein thrombosis. Dig Dis Sci 2008;53:2778-83. [PMID: 18343999 DOI: 10.1007/s10620-008-0225-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
12 Kalkanli S, Ayyildiz O, Tiftik N, Batun S, Isikdogan A, Ince H, Tekes S, Muftuoglu E. Factor V Leiden Mutation in Venous Thrombosis in Southeast Turkey. Angiology 2006;57:193-6. [DOI: 10.1177/000331970605700209] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
13 Kupeli E, Verdi H, Simsek A, Atac FB, Eyuboglu FO. Genetic Mutations in Turkish Population With Pulmonary Embolism and Deep Venous Thrombosis. Clin Appl Thromb Hemost 2011;17:E87-94. [DOI: 10.1177/1076029610385224] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
14 Schockman S, Glueck CJ, Hutchins RK, Patel J, Shah P, Wang P. Diagnostic ramifications of ocular vascular occlusion as a first thrombotic event associated with factor V Leiden and prothrombin gene heterozygosity. Clin Ophthalmol 2015;9:591-600. [PMID: 25897198 DOI: 10.2147/OPTH.S80714] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
15 Koshy A, Jeyakumari M. Prothrombin G20210A gene variant is not associated with idiopathic portal vein thrombosis in an area endemic for portal vein thrombosis. Ann Hematol. 2006;85:126-128. [PMID: 16283309 DOI: 10.1007/s00277-005-0020-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
16 Ağaoğlu N, Türkyılmaz S, Ovalı E, Uçar F, Ağaoğlu C. Prevalence of Prothrombotic Abnormalities in Patients with Acute Mesenteric Ischemia. World J Surg 2005;29:1135-8. [DOI: 10.1007/s00268-005-7692-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
17 Goren Sahin D, Bayraktutar BN, Yıldız Taş A, Akay OM, Ozkaya A, Yalcin Ö, Sahin A. Can Rotational Thromboelastometry be a New Predictive Tool for Retinal Vein Occlusion Development? Curr Eye Res 2019;44:406-12. [PMID: 30512971 DOI: 10.1080/02713683.2018.1554152] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
18 Harmanci O, Ersoy O, Gurgey A, Buyukasik Y, Gedikoglu G, Balkanci F, Sivri B, Bayraktar Y. The Etiologic Distribution of Thrombophilic Factors in Chronic Portal Vein Thrombosis. Journal of Clinical Gastroenterology 2007;41:521-7. [DOI: 10.1097/01.mcg.0000225635.52780.47] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
19 Jadaon MM. Epidemiology of Prothrombin G20210A Mutation in the Mediterranean Region. Mediterr J Hematol Infect Dis 2011;3:e2011054. [PMID: 22220251 DOI: 10.4084/MJHID.2011.054] [Cited by in Crossref: 27] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
20 Karagulle E, Turk E, Gokturk HS, Yildirim E, Moray G. Prothrombin 20210 G/A Defect as a Cause of Mesenteric Venous Infarction: Report of a Case. Surg Today 2007;37:251-3. [DOI: 10.1007/s00595-006-3381-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
21 Cakal B, Gokmen A, Yalinkilic M, Cakal E, Ayaz S, Nadir I, Ozin Y, Dagli U, Ulker A. Natural anticoagulant protein levels in Turkish patients with inflammatory bowel disease. Blood Coagulation & Fibrinolysis 2010;21:118-21. [DOI: 10.1097/mbc.0b013e328335d025] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]